Mechanistically, activation of P2RX7 leads to increased production of IL-18 in a NLRP3-dependent manner, which in turn activates NK and CD4+ T cells to produce IFN-γ and consequently increases tumor immunogenicity. The gene discussed is IL18; the disease is neoplasm.